130
Participants
Start Date
November 9, 2010
Primary Completion Date
October 15, 2011
Study Completion Date
October 15, 2011
Brodalumab
Administered as as an intravenous (IV) infusion over at least 30 minutes.
Placebo
Administered as as an intravenous (IV) infusion over at least 30 minutes.
Research Site, Birmingham
Research Site, Dothan
Research Site, Lowell
Research Site, Jacksonville
Research Site, Miami
Research Site, Hammond
Research Site, Chevy Chase
Research Site, Rochester
Research Site, Mexico
Research Site, Egg Harbor
Research Site, Great Neck
Research Site, Charlotte
Research Site, Wilmington
Research Site, Germantown
Research Site, Nashville
Research Site, San Antonio
Research Site, Logan
Research Site, Ogden
Research Site, Kurralta Park
Research Site, Box Hill
Research Site, Fitzroy
Research Site, Fremantle
Research Site, Bonheiden
Research Site, Ghent
Research Site, Leuven
Research Site, Roeselare
Research Site, Calgary
Research Site, Vancouver
Research Site, Victoria
Research Site, Winnipeg
Research Site, Hamilton
Research Site, London
Research Site, Toronto
Research Site, Montreal
Research Site, Lille
Research Site, Nice
Research Site, Paris
Research Site, Toulouse
Research Site, Vandœuvre-lès-Nancy
Research Site, Amsterdam
Research Site, Maastricht
Research Site, Rotterdam
Research Site, Bydgoszcz
Research Site, Olsztyn
Research Site, Opole
Research Site, Sopot
Research Site, Pontevedra
Research Site, Santiago de Compostela
Research Site, Barcelona
Research Site, Madrid
Lead Sponsor
Amgen
INDUSTRY